Lung Cancer through Transcription Factors
Author Contributions
Conflicts of Interest
References
- Kim, D.W.; Kim, K.C.; Kim, K.B.; Dunn, C.T.; Park, K.S. Transcriptional deregulation underlying the pathogenesis of small cell lung cancer. Transl. Lung Cancer Res. 2018, 7, 4–20. [Google Scholar] [CrossRef] [PubMed]
- Zhang, T.; Song, X.; Zhang, Z.; Mao, Q.; Xia, W.; Xu, L.; Jiang, F.; Dong, G. Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma. Oncogenesis 2020, 9, 92. [Google Scholar] [CrossRef] [PubMed]
- Sun, T.; Zhang, K.; Li, W.; Liu, Y.; Pangeni, R.P.; Li, A.; Arvanitis, L.; Raz, D.J. Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression. Cell Commun. Signal. 2022, 20, 147. [Google Scholar] [CrossRef] [PubMed]
- Mollaoglu, G.; Jones, A.; Wait, S.J.; Mukhopadhyay, A.; Jeong, S.; Arya, R.; Camolotto, S.A.; Mosbruger, T.L.; Stubben, C.J.; Conley, C.J.; et al. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment. Immunity 2018, 49, 764–779.e9. [Google Scholar] [CrossRef]
- Shia, D.W.; Choi, W.; Vijayaraj, P.; Vuong, V.; Sandlin, J.M.; Lu, M.M.; Aziz, A.; Marin, C.; Aros, C.J.; Sen, C.; et al. Targeting PEA3 transcription factors to mitigate small cell lung cancer progression. Oncogene 2023, 42, 434–448. [Google Scholar] [CrossRef]
- Guo, J.; Liu, Y.; Lv, J.; Zou, B.; Chen, Z.; Li, K.; Feng, J.; Cai, Z.; Wei, L.; Liu, M.; et al. BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors. J. Clin. Investig. 2021, 131, e133090. [Google Scholar] [CrossRef]
- Tang, S.; Xue, Y.; Qin, Z.; Fang, Z.; Sun, Y.; Yuan, C.; Pan, Y.; Zhao, Y.; Tong, X.; Zhang, J.; et al. Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment. Natl. Sci. Rev. 2023, 10, nwad028. [Google Scholar] [CrossRef] [PubMed]
- Yu, M.; Chen, Y.; Li, X.; Yang, R.; Zhang, L.; Huangfu, L.; Zheng, N.; Zhao, X.; Lv, L.; Hong, Y.; et al. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD. Cell Death Dis. 2018, 9, 464. [Google Scholar] [CrossRef] [PubMed]
- Gumbleton, M.; Snyder, E.L. TTF-1 and immune checkpoint therapy in non-small cell lung cancer. Transl. Lung Cancer Res. 2023, 12, 398–400. [Google Scholar] [CrossRef] [PubMed]
- Rudin, C.M.; Poirier, J.T.; Byers, L.A.; Dive, C.; Dowlati, A.; George, J.; Heymach, J.V.; Johnson, J.E.; Lehman, J.M.; MacPherson, D.; et al. Molecular subtypes of small cell lung cancer: A synthesis of human and mouse model data. Nat. Rev. Cancer 2019, 19, 289–297. [Google Scholar] [CrossRef] [PubMed]
- Papavassiliou, K.A.; Papavassiliou, A.G. Tackling the “Bottleneck” of Non-Small Cell Lung Cancer Pathobiology. Arch. Med. Res. 2023, in press. [CrossRef] [PubMed]
- Papavassiliou, K.A.; Marinos, G.; Papavassiliou, A.G. Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC). Cells 2023, 12, 871. [Google Scholar] [CrossRef] [PubMed]
- Papavassiliou, K.A.; Marinos, G.; Papavassiliou, A.G. Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC. Cancers 2023, 15, 386. [Google Scholar] [CrossRef] [PubMed]
- Otálora-Otálora, B.A.; López-Kleine, L.; Rojas, A. Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer. Curr. Issues Mol. Biol. 2023, 45, 434–464. [Google Scholar] [CrossRef] [PubMed]
- Amalraj, T.; Dravid, A.A.; Tripathi, R.; Lulu, S.S. Database of transcription factors in lung cancer (DBTFLC): A novel resource for exploring transcription factors associated with lung cancer. J. Cell Biochem. 2018, 119, 5253–5261. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Papavassiliou, K.A.; Anagnostopoulos, N.; Papavassiliou, A.G. Lung Cancer through Transcription Factors. Int. J. Mol. Sci. 2023, 24, 9461. https://doi.org/10.3390/ijms24119461
Papavassiliou KA, Anagnostopoulos N, Papavassiliou AG. Lung Cancer through Transcription Factors. International Journal of Molecular Sciences. 2023; 24(11):9461. https://doi.org/10.3390/ijms24119461
Chicago/Turabian StylePapavassiliou, Kostas A., Nektarios Anagnostopoulos, and Athanasios G. Papavassiliou. 2023. "Lung Cancer through Transcription Factors" International Journal of Molecular Sciences 24, no. 11: 9461. https://doi.org/10.3390/ijms24119461